Tests génétiques en entreprise.
SUMMARY The development of genetics, the decryptage of the human genome, and the possibilities foreseen for the creation of new methods of medical treatment are generally seen as the expression of progress, and so is the potential for better prevention of diseases, handicaps and disabilities. Acc...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Article ou chapitre numérique |
| Langue: | Français |
| Publié: |
2003
|
| Accès en ligne: | Accès Université d'Orléans et IFPM Accès Université d'Orléans et IFPM |
| Résumé: | SUMMARY
The development of genetics, the decryptage of the human genome, and the
possibilities foreseen for the creation of new methods of medical treatment are
generally seen as the expression of progress, and so is the potential for better
prevention of diseases, handicaps and disabilities. Accordingly, the market potential
of genetic tests seems to be enormous. It already has led to important investments by
laboratories, particularly in the United States, where testing kits might be free for
sale to everybody wishing to apply them to test himself.
Does this mean that we should enjoy full autonomy in all regards of self-testing, of
medical prevention, and of selection of persons for insurance coverage, labor
contract or professional career ? The debate on genetic testing is the more acute in
the latter areas as it is the firm where both the testing material will be manufactured,
and actually applied for selection purposes, and as the overall economic costs of
work accidents and professional diseases might become subject to more efficient
control.
The debates which, in France, deal with this issue are rather controversial as main
principles of labor law and of social law, in particular principles of protecting human
dignity and personal privacy, are at stake, and as the nature of the technical and
medical progress brought about by genetic testing is as ambivalent as the allegedly
concomitant social progress. |
|---|